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Abstract
Background: Agrobacterium vitis is a causal agent of crown-gall disease. Trifolitoxin (TFX) is a
peptide antibiotic active only against members of a specific group of α -proteobacteria that includes
Agrobacterium and its close relatives. The ability of TFX production by an avirulent strain of
Agrobacterium to reduce crown gall disease is examined here.
Results: TFX was shown to be inhibitory in vitro against several A. vitis strains. TFX production,
expressed from the stable plasmid pT2TFXK, conferred biological control activity to an avirulent
strain of A. vitis. F2/5, against three virulent, TFX-sensitive strains of A. vitis tested on Nicotiana
glauca. F2/5(pT2TFXK) is significantly reduces number and size of galls when co-inoculated with
tumorigenic strain CG78 at a 10:1 ratio, but is ineffective at 1:1 or 1:10 ratios. F2/5(pT2TFXK) is
effective when co-inoculated with tumorigenic strain CG435 at 10:1 and 1:1 ratios, but not at a
1:10 ratio. When F2/5(pT2TFXK) is co-inoculated with CG49 at a 10:1 ratio, the incidence of gall
formation does not decline but gall size decreases by more than 70%. A 24 h pre-inoculation with
F2/5(pT2TFXK) does not improve biological control at the 1:10 ratio.
Conclusions: TFX production by an avirulent strain of Agrobacterium does confer in that strain the
ability to control crown gall disease on Nicotiana glauca. This is the first demonstration that the
production of a ribosomally synthesized, post-translationally modified peptide antibiotic can confer
reduction in plant disease incidence from a bacterial pathogen.
Background
Agrobacterium vitis strains are causative agents of crown
gall, an economically important disease [1,2]. A. vitis F2/
5 is an effective biological control agent against many A.
vitis tumorigenic strains [3]. Strain F2/5 produces an anti-
biotic toxic to many A. vitis strains in vitro. However, two
lines of evidence suggest that this antibiotic plays a minor
role in disease suppression. Strains that are susceptible to
the antibiotic in vitro, such as A. vitis strain CG78, are able
to infect the plant in the presence of F2/5 [3], and Tn5 mu-
tants of F2/5 lacking F2/5 antibiotic production appear to
be unaffected in crown gall biological control [4]. Biolog-
ical control by F2/5 is grape-specific, as F2/5 is not effec-
tive on non-grapevine host plants such as Nicotiana glauca.
Furthermore, F2/5 is not effective against all A. vitis strains
[3]. Thus, enhancing the F2/5 biological control pheno-
type and extending the host range of the efficacy of F2/5
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beyond grape would be beneficial for disease control in
field applications.
Agrobacterium rhizogenes strain K84 is the most studied
crown gall biological control strain and is commercially
utilized for crown gall disease control worldwide. Strain
K84 biological control is primarily due to production of
two plasmid-encoded antibiotics, agrocins 84 and 484,
encoded by genes on pAgK84 and pAgK434 respectively
[5]. Agrocin 84, an adenosine analog [6], is effective
against tumorigenic strains carrying nopaline/agroci-
nopine tumor-inducing plasmids, and requires the acc
system in the target strain for activity [7]. Agrocin 434, a
di-substituted cytidine analog, is effective against, and
specific for, a broad range of A. rhizogenes strains [8]. Cur-
ing of either agrocin-encoding plasmid results in reduc-
tion of biological control activity [9]. Thus, K84
demonstrates the efficacy of antibiosis for crown gall bio-
logical control. However, the commercial application of
the K84 biological control system is limited where Agro-
bacterium strains of certain crops are not inhibited by K84.
As a result, alternative biological control systems for
crown gall disease are needed.
Trifolitoxin (TFX) is a peptide antibiotic produced by
Rhizobium leguminosarum bv. trifolii T24. Antibiotic pro-
duction and resistance functions are encoded by the sev-
en-gene tfx operon and the unlinked tfuA gene [10,11].
TFX is derived from post-translational cleavage and mod-
ification of the tfxA gene product. TFX effectively inhibits
growth of members of the α -proteobacteria including
strains of Brucella, Ochrobactrum, Rhodobacter, Rhodospeu-
domonas, Rhizobium, and the etiological agent of crown
gall disease, Agrobacterium[12]. TFX is highly specific for
this group, as demonstrated by a lack of observable effect
on the majority of the bacterial population in the bean
rhizosphere [13]. This suggests that TFX could be used to
control crown gall diseases of various plants with limited
effects on non-target bacteria outside of that very specific
group of TFX-sensitive α -proteobacteria. TFX is rapidly de-
graded in nonsterile soil but is readily extractable from
sterile soil inoculated with a TFX-producing strain, sug-
gesting that TFX is sensitive to in situ proteolysis [14]. De-
spite this rapid turnover, TFX production confers
enhanced nodulation efficiency upon TFX-producing
Rhizobium strains under field conditions [15].
Degradation of antimicrobial peptides such as cecropin B
and attacin E also has been observed in plant apoplastic
fluids [5,16,17]. This is likely due to apoplastic proteinas-
es [5,16]. Expression of antimicrobial peptides in plants
has had mixed results for enhancing disease resistance.
For example, cecropin expression in transgenic tobacco
did not confer resistance to P. syringae pv tabaci[18], likely
due to low apoplastic peptide concentrations due to pro-
teolysis [19]. Therefore, prior to this work it was not clear
whether a peptide antibiotic could play a role in the inhi-
bition of galling by tumorigenic Agrobacterium in planta.
Agrobacterium rhizogenes is capable of producing TFX by
addition of the stable plasmid, pT2TFXK, which contains
the tfx operon but not tfuA[11,12,20]. This suggests that
TFX production by crown gall biological control strains of
Agrobacterium, such as A. rhizogenes K84 and A. vitis F2/5,
may be enhanced by TFX production. These strains would
be excellent delivery vehicles for TFX to the infection
court.
Here we present experiments demonstrating the TFX-sen-
sitivity of a range of A. vitis strains and the effect of the TFX
production and resistance phenotypes on the expression
of biological control of crown gall using the model plant
Nicotiana glauca. Strain F2/5 was chosen as the recipient of
the TFX genes in this work because it is an avirulent strain
that expresses a biological control phenotype on only one
host. As a result, F2/5 is an ideal strain in which to test the
ability of the TFX system to confer biological control of
crown gall disease and to broaden the host-range efficacy
of a known biological control strain.
Results
In vitro TFX antibiosis against A. vitis
Agrobacterium vitis strains (Table 1) were tested for sensi-
tivity to trifolitoxin. As expected based on previous results
[12], the tested Agrobacterium vitis strains were sensitive to
TFX-producing strains. However, the level of susceptibility
was lower than predicted based upon previous TFX sensi-
tivity measurements with CG48 and CG74 [12]. No zones
of A. vitis growth inhibition were observed around R. legu-
minosarum T24 colonies, and only relatively small zones
were observed around R. etli CE3(pT2TFXK), which pro-
duces more TFX than T24. Furthermore, one A. vitis strain,
F2/5, was TFX-resistant.
Because A. vitis F2/5 produces an antibiotic to which most
of the tumorigenic strains are sensitive [3], the effect of
TFX on A. vitis was assessed against TFX-producing and
non-producing  Rhizobium strains. None of the tested
strains were sensitive to R. leguminosarum T24, which pro-
duces relatively low amounts of TFX. All of the A. vitis
strains except for F2/5 were sensitive to R. etli
CE3(pT2TFXK) as evidenced by zones of growth inhibi-
tion around the CE3(pT2TFXK) colonies. A. vitis growth
was not inhibited by a non-TFX metabolite or nutrient
competition by CE3(pT2TFXK) as evidenced by the lack of
a zone around the near-isogenic tfxA mutant
CE3(pT2TX3K) colony (Fig. 1). Wild type F2/5 produces a
zone of inhibition versus the other agrobacteria used in
this work. This occurred because of the antibiotic produc-
tion previously observed by F2/5. These zones of inhibi-BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/2
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tion were much larger when pT2TFXK was added to F2/5
and unchanged with the addition of pT2TX3K.
Evidence for TFX production by A. vitis strain F2/
5(pT2TFXK)
Strain F2/5(pT2TFXK) inhibited TFX-sensitive R. legumi-
nosarum bv. trifolii ANU794 but had no effect on
ANU794 following addition of the TFX resistance genes
provided by pT2TX3K (Fig. 2). Plasmids pT2TFXK and
pT2TX3K confer resistance to TFX, tetracycline, and kan-
amycin with pT2TFXK also providing TFX production to a
host strain [20]. Since strains F2/5 and F2/5(pT2TX3K)
produced no zones of inhibition against ANU794 or
ANU794(pT2TX3K) (data not shown), F2/5(pT2TFXK) is
producing TFX. In addition, this shows that the agrocin-
like molecule produced by F2/5 does not inhibit
ANU794.
In planta biological control of crown gall conferred by TFX 
production
As expected, F2/5 did not inhibit galling by tumorigenic
A. vitis strains on N. glauca. However, a 10:1 ratio of A. vi-
tis F2/5(pT2TFXK):pathogen caused a statistically signifi-
cant reduction in mean gall size relative to the TFX non-
producing controls on N. glauca stems for all three tested
tumorigenic strains (Figs. 3 and 4). High concentrations
of F2/5(pT2TFXK) also reduced gall incidence for CG435
and CG78, but not for CG49 (Table 2). A 1:1 ratio of F2/
5(pT2TFXK):CG435 also resulted in a significant reduc-
tion in gall size and in gall incidence compared to con-
trols. A 1:1 ratio of F2/5(pT2TFXK):CG49 or F2/5
Table 1: Bacterial Strains used in this work and their TFX phenotype (production, resistance, and sensitivity). Overproduction of TFX 
occurs when the TFX production is conferred using a multi-copy, broad host range plasmid such as pT2TFXK.
Strain Characteristics Reference
Rhizobium
T24 R. leguminosarum bv. trifolii, TFX producing strain 28
T24::Tn5-1 TFX non-producing mutant, Tn5 insertion in tfxB 10
CE3(pT2TFXK) R. etli. Contains TFX-encoding plasmid, overproduces TFX 20
CE3(pT2TX3K) Plasmid contains tfxA deletion, non-TFX producing strain 20
ANU794 R. leguminosarum bv. trifolii, TFX-sensitive 29
ANU794(pT2TX3K) TFX-resistant This work
Agrobacterium vitis
F2/5 Biological control on grapevine, no control on other host-plant species, TFX-resistant 30
F2/5(pT2TFXK) Contains TFX-encoding plasmid, produces TFX, TFX-resistant This work
F2/5(pT2TX3K) Plasmid contains tfxA deletion, non-TFX producing strain, TFX-resistant This work
CG49 Tumorigenic, nopaline-type Ti plasmid, controlled by F2/5, sensitive to TFX overproduction 31
CG78 Tumorigenic, vitopine-type Ti plasmid, not controlled by F2/5 co-inoculation, sensitive to TFX overproduction from TJ Burr
K306 Tumorigenic, octopine-type Ti plasmid, controlled by F2/5, sensitive to TFX overproduction from TJ Burr
CG107 Tumorigenic, sensitive to TFX overproduction from TJ Burr
CG113 Tumorigenic, TFX-sensitive from TJ Burr
CG435 Tumorigenic, TFX-sensitive from TJ Burr
Figure 1
In vitro TFX antibiosis assay against A vitis CG78. Legend: The
indicated TFX producing strains and their non-producing
mutant derivatives cultured as a single colony near the cent-
ers of the plates and allowed to grow 4 days at 27°C. The
plates were then misted with a dilute suspension of A. vitis
CG78. The plates were photographed two days following
misting. A zone of growth inhibition is present around the R.
etli CE3(pT2TFXK) colony, but not around any of the other
colonies.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/2
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(pT2TFXK): CG78 did not affect either incidence of galls
or reduce gall size. Similarly, an excess (a 1:10 ratio) of
any of the virulent strains to F2/5(pT2TFXK) resulted in a
high incidence of disease and large gall size.
Discussion
As all strains of A. vitis tested were sensitive to TFX both in
this work and in a previous study [12], experiments were
conducted to determine the effectiveness of a TFX-produc-
ing, avirulent strain of A. vitis in the prevention of crown
gall caused a three strains of A. vitis. Although A. vitis F2/
5 is an effective crown-gall biological control agent
against most tumorigenic A. vitis strains when co-inoculat-
ed with a tumorigenic strain, it is not an effective against
all strains of A. vitis.
Where  A. vitis F2/5 is effective as a biological control
agent, its control is only effective when numbers of F2/5
are equal to, or greater than, the number of cells of the vir-
ulent strain [3]. Strains that are resistant to F2/5 biological
control are known. For example, strain CG78 is not con-
trolled when co-inoculated with F2/5 [1].
Two principle benefits of TFX production by F2/5 are
demonstrated here. Biological control is extended to a
new host, N. glauca. Furthermore, biological control is ex-
tended to a strain that F2/5 fails to control (CG78). These
effects are due to TFX production as demonstrated by the
lack of efficacy of F2/5 against CG49, CG435, and CG78,
and by the lack of efficacy of the near-isogenic TFX-non-
producing F2/5(pT2TX3K) against CG78. TFX confers bi-
ological control when the TFX-producing strain is present
in excess of the tumorigenic strain. Thus, F2/5(pT2TFXK)
effectively inhibited gall incidence by two of the three test-
ed tumorigenic strains when co-inoculated in approxi-
mately 10-fold excess. F2/5(pT2TFXK) inhibited gall size
by more than 70% with third tumorigenic strain tested. At
1:1 or 1:10 inoculum ratios of F2/5(pT2TFXK):pathogen
biological control was reduced or lost. High ratios of bio-
logical control: pathogen strain should be easily achieved
in field situations by dipping the roots of planting stock in
suspensions of the biological control strain, or by directly
applying the bacterial suspension to the planting bed. Fur-
thermore, TFX is inhibitory towards all tested species of
Agrobacterium[12]. These results suggest that TFX produc-
tion would enhance crown gall biological control for oth-
er biological control strains, such as A. rhizogenes K84, and
on other host plants, especially where a mixed inoculum
of different tumorigenic Agrobacterium species occurs.
K84 biological control is thought to be primarily due to
production of two plasmid-encoded antibiotics, each of
which accounts for a portion of the observed disease con-
trol [9]. This naturally occurring example suggests that
Table 2: Proportion of inoculations that resulted in gall formation by the tumorigenic A. vitis strains (CC49, CG78, and CG435) when 
co-inoculated with the TFX-producing strain F2/5(pT2TFXK) or the non-producing strains, F2/5 or F2/5(pT2TX3K).
Tumorigenic Straina. Proportion of inoculations that resulted in gall formation.
Biological control CG49 CG78 CG435
Strain
F2/5 12/12 6/6 12/12
F2/5(pT2TFXK) 10/14 1/8 0/14
F2/5(pT2TX3K) NDb 8/8 ND
a. Inoculations performed at 10:1 ratio of biological control:pathogenic strain. Presence of galls was scored visually by comparison to an uninocu-
lated negative control one month post-inoculation. b. ND, not done.
Figure 2
Ability of Agrobacterium to produce TFX with addition of
pT2TFXK. Legend: Ability of F2/5(pT2TFXK) to inhibit
ANU794. This inhibition is reversed by the addition of the
TFX resistance genes to ANU794. Assay was performed as
described in Figure 1 with F2/5(pT2TFXK) cultured in a sin-
gle colony in the center of the plate. One day after growth at
28°C, the plates were sprayed with a dilute suspension of
ANU794(pT2TX3K) (A) or ANU794 (B).
A BBMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/2
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pyramiding biological control mechanisms within one
strain can enhance disease control. Strain F2/5 also pro-
duces an A. vitis-specific antibiotic in vitro, but this antibi-
otic is not involved in disease control [4]. Thus, the
addition of TFX to F2/5 is a successful example of pyra-
miding unrelated disease control mechanisms and clearly
demonstrates that individual antibiotics can be effectively
developed as a mechanism of disease control.
Although plasmid-borne traits are frequently unstable,
pT2TFXK contains the RK2 plasmid-partitioning locus
that confers a high degree of stability both in vitro and un-
der field conditions [15]. Stable TFX expression would be
beneficial under field conditions when the biological con-
trol agent is inoculated on seeds or on roots dipped in a
bacterial suspension prior to planting.
Trifolitoxin production enhances rhizosphere competi-
tiveness of Rhizobium etli CE3 (pT2TFXK) in sterile soil
and enhances nodulation efficiency in non-sterile soil
when compared to a TFX-sensitive strain [20]. Trifolitoxin
production also increases bean nodulation competitive-
ness of Rhizobium etli CE3 in the presence of indigenous
rhizobia under agricultural conditions [15]. Field applica-
tion of R. etli CE3 (pT2TFXK) dramatically reduced the di-
versity of indigenous α -proteobacteria in the bean
rhizosphere without affecting unrelated species [13].
Thus, TFX production by A. vitis F2/5 should enhance the
competitiveness and aid in establishment of this benefi-
cial strain in the rhizosphere. The ability to displace indig-
enous tumorigenic Agrobacterium strains would be
beneficial in those areas already infested with the patho-
gen.
Compared to other treatments available for pathogenic
agrobacteria, the effects of TFX on non-target species is
very low. Copper, a broad spectrum bacteriocide, is com-
monly used as a treatment of bacterial diseases. Although
no comprehensive studies have been published on the
taxonomic range of bacteria inhibited by K84, it is known
that K84 produces multiple antibiotics and that K84 can
inhibit strains of Erwinia and Pseudomonas that are unaf-
fected by TFX [23–25]. TFX-producing strains inhibit only
a very specific group within the α -proteobacteria in cul-
ture and in the field [13,26]. These observations suggest
that a K84-producing strain may have a more serious im-
Figure 3
Effect of TFX production and inoculum ratio on gall forma-
tion. Legend: Nicotiana glauca stems were wounded with a
dissecting needle, and 5 ul of inoculum (mixtures noted at
left) was placed on the wounds. The top stem was inoculated
with CG435 as a positive control. Stems 2 and 3 were inocu-
lated with mixtures of biological control test strains and
CG435 at either a 1:1 (left three inoculation sites on each
stem) or 10:1 (right three inoculation sites) biological con-
trol:pathogen ratios. The photograph was taken approxi-
mately 2 months post-inoculation. pT2TFXK confers
biological control on F2/5 at the 10:1 ratio, but not at the 1:1
ratio.
Figure 4
Effect of TFX production and inoculum ratio on Nicotiana
glauca gall size. Legend: Gall diameter (mm) perpendicular to
the stem was measured 1 month post-inoculation. Wound
sites were inoculated with 5 µl of mixed bacterial suspen-
sions. Mixtures were made immediately prior to inoculation.
Each inoculum mixture was inoculated into three or four
wounds on each of two plants, for a total of six to eight inoc-
ulations per treatment. Results that are significantly different
at α  = 0.05 are indicated with different letters within a group
of inoculum mixtures. High ratios of F2/5 (pT2TFXK) :tum-
origenic strain result in significant disease suppression for all
three tested tumorigenic strains.
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pact on non-target organisms than does a TFX-producing
strain. However, there has been no study of the effects of
K84 on non-target soil bacteria by culture-independent
means to compare the effects of K84 versus the TFX system
in a natural system.
Conclusions
TFX production effectively enhances crown gall biological
control by Agrobacterium vitis F2/5. The host-plant range
and range of tumorigenic A. vitis strains controlled by F2/
5 are both broadened by TFX production. In addition, vir-
ulent strains of A. vitis not previously controlled by F2/5
are controlled following the addition of the trifolitoxin
production and resistance genes to F2/5. The plasmid
used to confer trifolitoxin production and resistance,
pT2TFXK, is stably maintained in the absence of selection
pressure [20]. This plasmid is not self-transmissible but is
mobilizable. With the TFX system, the biological control
of  Agrobacterium pathogens may be extended to many
crops far beyond what is possible today with currently
available commercial products.
Materials and Methods
Bacterial and plant growth conditions, strain construction
Bacterial strains are listed in Table 1. The A. vitis strains
(without pT2TFXK or pT2TX3K) were obtained from Dr.
T.J. Burr, Cornell University. Bacteria were grown on BSM
agar [21] media at 27°C. A. vitis F2/5(pT2TFXK) and F2/
5(pT2TX3K) were constructed by triparental mating using
standard procedures. Transconjugants were selected on
BSM media amended with 50 µg/ml kanamycin. Trimeth-
oprim (10 µg/ml) was added to counterselect the E. coli
DH5α  donor and helper strains. The helper strain was E.
coli DH5a pRK2013 [27]. Strains containing the plasmids
pT2TFXK and pT2TX3K were grown for routine propaga-
tion on BSM amended with 50 µg/ml kanamycin. Prior to
use in making inoculum suspensions for biological con-
trol assays these strains were grown overnight on BSM
agar without kanamycin.
Plants (Nicotiana glauca) were grown in the greenhouse
with supplemental illumination and fertilized as needed
with a nutrient solution called CNS containing (2 mM
CaCl2.2H2O, 0.5 mM MgSO4.7H2O, 2 mM KCl, 0.4 mM
KH2PO4, 2.5 mM NH4NO3, 0.065 mM FeSO4.7H2O, 2.3
µM H3BO3, 0.9 µM MnSO4.H2O, 0.6 µM ZnSO4.7H2O,
0.1 µM NaMoO4.2H2O, 0.11 µM NiCl2.6H2O, 0.01 µM
CoCl2.6H2O, 0.15 µM CuSO4.5H2O).
In vitro antibiosis assay
TFX antibiosis assays were performed as described previ-
ously [11]. The effect of TFX on various Agrobacterium vitis
strains (Table 1) was assessed using Rhizobium leguminosa-
rum bv. trifolii strain T24 and R. etli strain CE3 (pT2TFXK)
as producing strains. Rhizobium leguminosarum bv. trifolii
T24::Tn5-1 and R. etli CE3 (pT2TX3K) were used as TFX
non-producing negative controls.
In planta biological control of crown gall by TFX-produc-
ing strains
Agrobacterium vitis strains were suspended in sterile dis-
tilled water prior to the determination of colony forming
units (CFU) per ml. These suspensions were adjusted to
OD650 0.10 (approximately 108 CFU/ml) using a Shi-
madzu UV-160 spectrophotometer and sterile distilled
water, and stored until inoculation at 4°C. Actual inocu-
lum viability and cell density were measured by dilution
plating on BSM agar medium on the day that plants were
inoculated [22]. Prior to inoculation, tumorigenic strains
were diluted 10-fold with sterile distilled water to approx-
imately 107 CFU/ml. Strain F2/5 and its derivatives were
left undiluted, or diluted 10-fold (for CG49 and CG435
experiments) or 100-fold (for CG78 experiments). Thus,
the CFU ratios were approximately 10:1, and 1:1 or 1:10
avirulent:tumorigenic strain. Immediately prior to plant
inoculation tumorigenic strains were mixed 1:1 (vol:vol)
with the appropriate biological control test strain. Positive
controls were diluted 1:1 (vol:vol) with water. Thus, all
plant inoculum contained approximately 5 ×  106 CFU/ml
of the tumorigenic strains. Plants (Nicotiana glauca) were
inoculated by wounding the stem with a dissecting nee-
dle. Three or four inoculations were made per inoculum
mixture on each of two plants. Thus, each of the two ex-
periments included 6 to 8 repetitions per treatment. A 5 µl
drop of bacterial suspension was placed on the wound
and allowed to air dry. Inoculation sites were wrapped
loosely with Parafilm (American National Can) for 1
week post-inoculation. Gall diameter perpendicular to the
long axis of the stem was measured 4 to 7 weeks post-in-
oculation using a caliper, and all measurements were in-
cluded for statistical analysis. Results were analyzed using
ANOVA at the α  = 0.05 level of significance.
Abbreviations
TFX, trifolitoxin.
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